The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schade Christian S since 2013.
This trader's CIK number is 1214496.
At the time of last reporting, Schade Christian S was the Chairman & CEO of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | OMTH | 0 | $0 | 0 | $0 | 316,292 | $657,887 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | IART | 0 | $0 | 15,658 | $807,326 | 15,658 | $343,927 |
| 2018 | IART | 0 | $0 | 15,658 | $827,995 | 15,658 | $282,783 |
| 2016 | IART | 0 | $0 | 7,829 | $551,310 | 7,829 | $322,633 |
| 2014 | IART | 0 | $0 | 7,500 | $352,920 | 7,500 | $186,150 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | APRE | 37,500 | $24,112 | 0 | $0 | 0 | $0 |
| 2019 | APRE | 11,000 | $165,000 | 0 | $0 | 0 | $0 |
1. Omthera Pharmaceuticals, Inc. (OMTH)
2. Integra Lifesciences Holdings Corp (IART)
3. Aprea Therapeutics, Inc. (APRE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-16 | OMTH | Option Ex | 316,292 | 2.08 | 657,887 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-10 | IART | Option Ex | 15,658 | 21.96 | 343,927 |
| 2019-05-10 | IART | Sale | 15,658 | 51.56 | 807,326 |
| 2018-03-05 | IART | Option Ex | 15,658 | 18.06 | 282,783 |
| 2018-03-05 | IART | Sale | 15,658 | 52.88 | 827,995 |
| 2016-05-03 | IART | Option Ex | 7,829 | 41.21 | 322,633 |
| 2016-05-03 | IART | Sale | 7,829 | 70.42 | 551,310 |
| 2014-02-28 | IART | Option Ex | 7,500 | 24.82 | 186,150 |
| 2014-02-28 | IART | Sale | 7,500 | 47.06 | 352,920 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-18 | APRE | Buy | 37,500 | .64 | 24,112 |
| 2019-10-07 | APRE | Buy | 11,000 | 15.00 | 165,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schade Christian S (Chairman & CEO of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.